Kyle T Amber

29PUBLICATIONS

26CO-AUTHORS

Molecular targetsAllergyNaturopathyPanel data analysisMedical mycology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (29)

Sort by Publication Date:

|May 13, 2026

CD24 in Melanoma: Biomarker, Innate Immune Checkpoint and Emerging Therapeutic Target.

|May 08, 2026

The Secretome of Bullous Pemphigoid IgG-Treated Keratinocytes Induces a Pro-Inflammatory Eosinophil Response.

|Mar 18, 2026

Review of Low-Dose Naltrexone for Hailey-Hailey Disease Suggests Lack of Benefit in Dose Escalation.

Yulu Wang, Haley R Gainer, Claudia Lasalle

|Aug 28, 2025

Development of Superficial Thrombophlebitis and Subsequent Central Retinal Vein Occlusion Occurring in a Patient Receiving IVIg for Ocular Pemphigoid.

Kevin Truong-Balderas, Maria Mihailescu, Grace Tu

|Aug 06, 2025

IgG autoantibodies in bullous pemphigoid induce a pathogenic MyD88-dependent pro-inflammatory response in keratinocytes.

Lei Bao, Christian F Guerrero-Juarez, Jing Li

|Jun 20, 2025

Cost implications of European guidelines for whole-body clobetasol for pemphigoid in the United States.

Sabrina F Schundler, Maria L Mihailescu, Kyle T Amber

Pageof 5

Frequent Collaborators

Payal M Patel

K Kridin

Virginia A Jones

Yulu Wang

Adrian P Mansini

Claudia Lasalle

Haley R Gainer

A D Cohen

Frederick T Gibson

Christian F Guerrero-Juarez

Frequent Collaborators

Payal M Patel

K Kridin

Virginia A Jones

Yulu Wang